Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study-Reference-Cited by-同舟云学术

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

Published:2006 Issue:1 Volume:22 Page:4-12
ISSN:1015-9770
Container-title:Cerebrovascular Diseases
language:en
Short-container-title:Cerebrovasc Dis

Author:

Sacco Ralph L.,Prabhakaran Shyam,Thompson J.L.P.,Murphy Amy,Sciacca Robert R.,Levin Bruce,Mohr J.-P.

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Neurology

Reference22 articles.

1. Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic Attack

2. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

3. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke

4. Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Prevention of Lacunar Stroke;Ischemic Stroke Therapeutics;2024

2. White matter lesions as a prognostic marker of recurrence in cryptogenic stroke with high-risk patent foramen ovale;2023-09-04

3. Persistent Foramen Ovale Associated with Systemic Lupus as a Cause of Acute Ischemic Stroke - A Case Report;Experimental and Applied Biomedical Research (EABR);2023-04-22

4. Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System;Journal of Atherosclerosis and Thrombosis;2023-04-01

5. Current perspectives on the clinical management of cryptogenic stroke;Expert Review of Neurotherapeutics;2023-03-04